Transitioning from NIH-Funded to Pharmaceutical-Funded Trials: Leveraging Performance Metrics and Expertise
The funding landscape for clinical trials is undergoing a significant transformation. As grant support for NIH-funded studies continues to decline, clinical research sites and CROs are facing growing pressure to identify alternative sources of revenue. Increasingly, that source is the pharmaceutical industry. Making the transition from NIH-funded to pharmaceutical-funded trials requires a deliberate focus on … Read more

